Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsStudy adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.
The drug can now be administered with the hands-free automated CirCLIQ on-body injector.
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
FDA Approves Sickle Cell Gene Therapy for Young Kids
3.
According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.
4.
Research exposes far-reaching toll of financial hardship on patients with cancer
5.
Combination Treatment May Improve Multiple Myeloma Outcomes
1.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
2.
Integrated Techniques in Oncology in the Digital Era
3.
Quality of Life Optimization in Long-Term Cancer Survivorship
4.
Erythrocyte Functional Impairment During Critical Illness: Mechanisms, Clinical Implications, and Management
5.
Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge